Cholera Symptoms and Diagnosis

  1. What Is Vibrio cholerae?
  2. How Cholera Toxin Causes Diarrhea
  3. Global Burden of Cholera
  4. The 7th Pandemic
  5. Endemic Countries and High-Risk Settings
  6. How Rapid Dehydration Kills
  7. Clinical Spectrum: Mild to Severe
  8. Emergency Warning Signs
  9. Key Research
  10. Connections
  11. Featured Videos

What Is Vibrio cholerae?

Vibrio cholerae is a gram-negative, comma-shaped (curved rod) bacterium that lives naturally in warm coastal and estuarine waters. It belongs to the family Vibrionaceae and has a single polar flagellum that gives it rapid, darting motility. Under a microscope, the bacteria look like tiny curved slivers — sometimes described as "shooting stars" when viewed in fresh stool under dark-field microscopy.

There are over 200 serogroups of V. cholerae based on their O-antigen surface structure, but only two cause epidemic cholera: O1 and O139. The O1 serogroup has two biotypes — Classical and El Tor. El Tor now dominates all seven cholera pandemics and is the strain responsible for nearly every cholera outbreak today. El Tor produces a slightly different version of cholera toxin than the Classical biotype but causes equally severe disease.

The O1 serogroup is further divided into two serotypes, Ogawa and Inaba, which are important for surveillance but do not affect treatment. The O139 serogroup emerged in Bangladesh and India in 1992 and caused a brief scare of a possible 8th pandemic, but O1 El Tor has since remained dominant.

Infection occurs when a person swallows water or food contaminated with the bacteria. An infectious dose can be as low as 106 organisms in healthy adults, though people with reduced stomach acid (on antacids, or with achlorhydria) may become ill from far fewer bacteria because stomach acid normally kills V. cholerae before it reaches the small intestine.

How Cholera Toxin Causes Diarrhea

Cholera does not cause diarrhea by destroying intestinal cells or invading tissues — it works through a toxin that hijacks the normal function of the gut. This is why cholera diarrhea is so massive and so fast.

Once V. cholerae reaches the small intestine, it colonizes the surface of intestinal cells (enterocytes) without invading them. There it secretes cholera toxin (CT), a two-component protein. The B subunit binds to a specific receptor called GM1 ganglioside on the surface of enterocytes — it essentially glues itself to the cell. This allows the A subunit to enter the cell.

Inside the cell, the A subunit permanently activates an enzyme called adenylate cyclase, which drives a massive buildup of cyclic AMP (cAMP). Elevated cAMP forces chloride ion channels (CFTR channels) to stay open and pump chloride ions out of the cell into the gut lumen. Water follows the chloride through osmosis — essentially, the cell is forced to dump water into the intestine continuously.

At the same time, sodium absorption is inhibited. The result is an enormous net outflow of sodium, chloride, bicarbonate, and water into the intestinal lumen. The body cannot reabsorb the fluid fast enough. Output can reach 20 liters per day in the most severe cases — more than the body's entire blood volume.

This mechanism is irreversible at the cellular level once toxin binds — the effect lasts until those enterocytes are naturally shed and replaced (normally 2–3 days). This is why cholera diarrhea continues even after the bacteria are killed by antibiotics, though antibiotics do reduce its duration and severity.

Global Burden of Cholera

Cholera remains one of the world's most dangerous infectious diarrheal diseases, despite being entirely preventable with clean water and sanitation. The WHO estimates 1.3 to 4 million cases occur globally every year, with 21,000 to 143,000 deaths annually. The wide ranges reflect the reality that most cholera cases in low-income countries are never formally reported.

The true burden is almost certainly higher. Surveillance systems in endemic countries are often weak, healthcare access is limited, and many deaths occur at home or in transit to care — never counted in official statistics. Mathematical modeling studies suggest that reported cases may capture as few as 5–10% of actual cases.

Sub-Saharan Africa now bears the largest share of the global cholera burden, with the African continent accounting for more than 80% of cases reported to the WHO in recent years. Asia — particularly Bangladesh, India, and parts of Southeast Asia — remains a major endemic reservoir. Yemen's catastrophic outbreak beginning in 2016 became the largest single-country cholera outbreak in recorded history, with over 2.5 million suspected cases.

The economic cost is staggering. Beyond the human toll, cholera outbreaks devastate local economies, overwhelm health systems, and divert resources from other health priorities. Cholera consistently strikes hardest in communities with the least capacity to respond — displacement camps, post-conflict zones, and areas struck by natural disasters.

The 7th Pandemic

We are currently living through the 7th cholera pandemic, which began in 1961 in Sulawesi, Indonesia. Unlike the six previous pandemics (most of which started in India's Ganges delta), the 7th pandemic was caused by the El Tor biotype of V. cholerae O1 — a strain that was originally considered less virulent than the Classical biotype but proved far more persistent and transmissible.

From Indonesia, El Tor spread westward through Asia, reaching the Middle East and Africa by the 1970s. In 1991, cholera arrived in Latin America for the first time in over a century, erupting in Peru and rapidly spreading through Central and South America — infecting over a million people in just a few years.

In 2010, the devastating earthquake in Haiti created conditions for a massive outbreak that killed over 10,000 people and infected hundreds of thousands more — in a country that had not seen cholera in over a century. UN peacekeepers were later found to have introduced the strain from Nepal.

What makes El Tor so persistent is its ability to survive in aquatic environments as part of biofilms, its resistance to certain stresses, and its capacity to cause a high proportion of asymptomatic or mild infections — which means carriers can transmit the bacteria without knowing they are infected. The 7th pandemic shows no sign of ending, as endemic transmission continues across much of Africa, Asia, and the Middle East.

Endemic Countries and High-Risk Settings

Cholera is considered endemic — meaning it circulates year-round — in several countries with chronically inadequate water and sanitation infrastructure. The highest burden countries include:

Risk is highest in specific settings regardless of country: displacement camps and refugee settlements where thousands of people share water sources and latrines; areas flooded by heavy rains that contaminate wells and surface water; post-earthquake or post-conflict zones where water treatment stops; and urban slums without piped water or sewage treatment.

Travelers to endemic areas face risk primarily from drinking untreated water, ice, or raw seafood — particularly shellfish, which can concentrate V. cholerae from coastal waters.

How Rapid Dehydration Kills

Cholera kills through a cascade of events that moves from diarrhea to death in hours without treatment — one of the fastest death pathways of any infectious disease.

As massive fluid loss continues, blood volume drops (hypovolemia). The body responds by constricting blood vessels to maintain blood pressure, but this can only compensate for so long. As blood volume falls further, blood pressure drops — hypovolemic shock. The heart races to compensate (tachycardia), but output continues to fall as there is simply less fluid to pump.

Reduced blood flow to organs causes them to begin failing. The kidneys stop producing urine (acute renal failure). The brain, deprived of adequate blood flow, causes confusion and loss of consciousness. The heart, stressed by the rapid loss of electrolytes (especially potassium and bicarbonate), becomes prone to dangerous arrhythmias.

The average time from first watery stool to death without treatment in severe cholera can be as short as 2 to 4 hours in a previously healthy adult. In children and elderly patients, this window is even shorter. With prompt oral rehydration therapy, the death rate drops from 25–50% to under 1%.

Clinical Spectrum: Mild to Severe

Not everyone infected with V. cholerae develops the dramatic, life-threatening diarrhea that cholera is famous for. In fact, the majority of infections are either asymptomatic or cause only mild diarrhea indistinguishable from other causes of gastroenteritis.

The clinical spectrum breaks down roughly as follows:

Factors that increase the likelihood of severe disease include blood type O (see Children and Vulnerable Groups page), malnutrition, reduced stomach acid (from antacids or prior stomach surgery), and immune compromise. The infectious dose also matters — drinking highly contaminated water delivers more organisms, overwhelming stomach acid defenses more effectively.

Emergency Warning Signs

Anyone with suspected cholera should be evaluated urgently. The following signs indicate severe dehydration requiring immediate IV fluids — oral rehydration alone is not enough at this stage:

If any of these signs are present, the person needs intravenous Ringer's lactate or normal saline immediately — not just oral rehydration salts. Time to treatment is the single most important factor determining survival. In a cholera treatment center setting, trained staff can deliver 100 mL/kg of IV fluid in 3 hours to an adult with severe dehydration and turn around a near-death patient.

Key Research

  1. Ali M, et al. "Updated global burden of cholera in endemic countries." PLoS Negl Trop Dis. 2015;9(6):e0003832. PMID: 26043000
  2. Cholera Working Group. "Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal." Lancet. 1993;342(8868):387–390. PMID: 8101877
  3. Harris JB, et al. "Cholera." Lancet. 2012;379(9835):2466–2476. PMID: 22386858
  4. Sack DA, et al. "Cholera." Lancet. 2004;363(9404):223–233. PMID: 14738797
  5. Bhattacharya SK. "An evaluation of current cholera treatment." Expert Opin Pharmacother. 2003;4(2):141–146. PMID: 12562303
  6. Faruque SM, et al. "Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae." Microbiol Mol Biol Rev. 1998;62(4):1301–1314. PMID: 9841673
  7. Waldor MK, Mekalanos JJ. "Lysogenic conversion by a filamentous phage encoding cholera toxin." Science. 1996;272(5270):1910–1914. PMID: 8658163
  8. Kaper JB, et al. "Cholera." Clin Microbiol Rev. 1995;8(1):48–86. PMID: 7704895
  9. Mukhopadhyay AK, et al. "Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V. cholerae O1 biotype classical El Tor in Bangladesh." J Clin Microbiol. 2014;52(9):3381–3387. PMID: 25031443
  10. Chin CS, et al. "The origin of the Haitian cholera outbreak strain." N Engl J Med. 2011;364(1):33–42. PMID: 21142692
  11. Lam C, et al. "Cholera pathogenesis: from CT to CAMP and beyond." Curr Top Microbiol Immunol. 2020;426:35–56. PMID: 32060808

Connections

Back to Table of Contents